CFP
BSX icon

Catalyst Financial Partners’s Boston Scientific BSX Stock Holding History

Catalyst Financial Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$536K Sell
8,538
-940
-10% -$75.2K 0.06% 190
2025
Q4 		$904K Buy
9,478
+1,305
+16% +$128K 0.1% 111
2025
Q3 		$798K Buy
8,173
+182
+2% +$18.8K 0.1% 112
2025
Q2 		$858K Sell
7,991
-78
-1% -$7.89K 0.09% 96
2025
Q1 		$814K Buy
8,069
+942
+13% +$94.9K 0.15% 85
2024
Q4 		$637K Buy
7,127
+154
+2% +$13.6K 0.12% 107
2024
Q3 		$584K Sell
6,973
-62
-0.9% -$4.89K 0.11% 120
2024
Q2 		$542K Buy
7,035
+738
+12% +$54K 0.12% 113
2024
Q1 		$428K Buy
6,297
+683
+12% +$43.9K 0.11% 129
2023
Q4 		$325K Buy
5,614
+270
+5% +$14.4K 0.09% 153
2023
Q3 		$282K Buy
5,344
+307
+6% +$16.1K 0.09% 162
2023
Q2 		$272K Buy
5,037
+57
+1% +$2.98K 0.1% 153
2023
Q1 		$249K Sell
4,980
-80
-2% -$3.77K 0.11% 144
2022
Q4 		$234K Buy
+5,060
New +$219K 0.12% 142

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Catalyst Financial Partners's BSX Position: Q1 2026 in Review

Catalyst Financial Partners reduced its Boston Scientific (BSX) stake by 9.9% in Q1 2026, selling an estimated $75.2K and leaving 8,538 shares worth $536K. The position accounts for 0.06% of the portfolio, ranked #190.

Catalyst Financial Partners first reported a position in BSX in Q4 2022 and has held it in 14 quarters since. The position peaked at $904K in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Catalyst Financial Partners held 8,538 shares of Boston Scientific worth $536K as of Q1 2026.
  • Catalyst Financial Partners sold 940 Boston Scientific shares in Q1 2026, an estimated $75.2K.
  • Boston Scientific made up 0.06% of Catalyst Financial Partners's portfolio in Q1 2026, its #190 holding.
  • Catalyst Financial Partners first reported a position in Boston Scientific in Q4 2022 and has held it in 14 quarters since.
  • Catalyst Financial Partners's Boston Scientific position peaked at $904K in Q4 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Catalyst Financial Partners's 13F filing for Q1 2026, filed 12 May 2026.